Niva Bupa Health Insurance Company Fair Value
Niva Bupa Health Insurance Company (NIVABUPA) average fair value is ₹210.05 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹86.8 (+142.0%), fair value range ₹18.09–₹1023.2. Also explore NIVABUPA price trends to track price trends across different timeframes.
Fair Value Analysis Export
NIVABUPA Fair Value vs Current Price — Valuation Summary
NIVABUPA average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). See Niva Bupa Health Insurance Com P/B ratio trends to compare market price against book value per share.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
NIVABUPA Fair Value Analysis — Data Sources & Coverage
Niva Bupa Health Insurance Company financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit NIVABUPA share price screener.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
NIVABUPA vs Insurance Sector Peers — P/E, P/B & Market Cap
Niva Bupa Health Insurance Company P/E ratio, P/B ratio and market capitalisation vs Insurance sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Go Digit General Insuran… | GODIGIT | 51.03 | 5.96 | ₹27,370 |
| Canara HSBC Life Insuran… | CANHLIFE | 104.7 | 8.24 | ₹13,220 |
| ICICI Prudential Life In… | ICICIPRULI | 43.89 | 5.06 | ₹71,266 |
| HDFC Life Insurance | HDFCLIFE | 65.58 | 6.75 | ₹123,933 |
| LIC of India | LICI | 8.93 | 2.86 | ₹519,915 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.